Key result
Wearable cardioverter-defibrillator enables high compliance with zero shocks in a pediatric transplant candidate.
Why the study?
This case report describes long-term wearable cardioverter-defibrillator protection and monitoring in a pediatric patient with severely reduced ejection fraction and high arrhythmic risk awaiting heart transplantation.
Case Report (n=1)
No
This case demonstrates that a wearable cardioverter-defibrillator with remote telemonitoring can serve as a safe, well-tolerated, and high-compliance alternative to an implantable defibrillator for bridging a pediatric heart transplant candidate.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for wearable cardioverter-defibrillator use in pediatric transplant candidates; prospective studies needed before clinical adoption.
This case report presents a pediatric patient who was protected long-term with a wearable cardioverter-defibrillator (WCD) while awaiting heart transplantation. A 10-year-old girl with end-stage idiopathic dilated cardiomyopathy (likely genetic, with a DSP gene variant) and complex arrhythmias was managed using a WCD while awaiting a heart transplant. Because of her severely reduced ejection fraction (15%) and high arrhythmic risk, a WCD was chosen over an implantable defibrillator. Full telemonitoring allowed for continuous remote assessment. The patient wore the WCD for 194 days without receiving any treatment shocks. She maintained high compliance (23.21 h per day). Throughout the entire period, the girl reported her comfort as very good; the vest did not interfere with her daily activities, school attendance, or sleep. This case demonstrates that WCD can be a safe and effective alternative to temporary implantable cardioverter-defibrillator implantation in pediatric patients.
No takes yet. Share an insight, caveat, or question.
Wieniawski et al. (2026) conducted a case report in End-stage idiopathic dilated cardiomyopathy with complex arrhythmias awaiting heart transplantation (n=1). Wearable cardioverter-defibrillator (WCD) with full telemonitoring was evaluated on Treatment shocks and daily wear compliance. Wearable cardioverter-defibrillator management in a 10-year-old awaiting heart transplant resulted in 0 treatment shocks and high compliance over 194 days.
Synapse has enriched 10 related papers. Consider them for comparative context: